Joshua Patterson
Nessuna posizione attualmente
Patrimonio netto: 5 078 $ in data 30/04/2024
Storia della carriera di Joshua Patterson
Precedenti posizioni note di Joshua Patterson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GAMIDA CELL LTD. | Responsabile della Conformità | 01/08/2021 | 26/04/2024 |
| Consigliere Generale | 01/08/2021 | 26/04/2024 | |
| IONIS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/12/2006 | 01/03/2018 |
| Corporate Officer/Principal | 01/12/2006 | 01/03/2018 | |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/10/2000 | 01/09/2006 |
| AKCEA THERAPEUTICS, INC. | Consigliere Generale | 01/03/2018 | - |
| Segretario Aziendale | 01/03/2018 | 11/03/2020 |
Formazione di Joshua Patterson
| Carthage College | Undergraduate Degree |
| Syracuse University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Israele | 2 |
Posizioni
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
| Corporate Secretary | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Joshua Patterson
- Esperienza